Androgen receptor gene amplification: A novel molecular mechanism for endocrine therapy resistance in human prostate cancer

Scandinavian Journal of Clinical and Laboratory Investigation, Supplement

Volumn 56, Issue 226, 1996, Pages 57-64

  Koivisto, Pasi ^a,c   Visakorpi, Tapio ^a   Kallioniemi, Olli P ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

androgen receptor gene; gene amplification; hormone refractory; molecular genetics; prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN;

ARTICLE; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC ANALYSIS; HORMONAL THERAPY; HUMAN; MALE; MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; DRUG RESISTANCE; GENETICS; PROSTATE TUMOR; REVIEW;

ANDROGEN ANTAGONISTS; DRUG RESISTANCE, NEOPLASM; GENE AMPLIFICATION; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 0030333504     PISSN: 0085591X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kosary CL, Ries LAG, Miller AB, Hankey BF, Harras A, Edwards BK (eds.). SEER Cancer Statistics Review 1973-1992. Tables and graphs. National Cancer Institute. NIH Publications No. 96-2789, Bethesda, MD, USA.
2. Kallioniemi O-P, Visakorpi T. Genetic basis and clonal evolution of human prostate cancer. Adv Cancer Res 1996;68:226-55.
3. Beato M, Herrlich P, Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995;83:851-7.
4. Brinkmann AO, Jenster G, Kuiper GGJM, Ris C, van der Korput JAGM, Degenhart HJ, Trifiro MA, Pinsky L, Romalo G, Schweikert HU, Veldscholte J, Mulder E, Trapman J. The human androgen receptor: Structure/function relationship in normal and pathological situations. J Steroid Biochem Molec Biol 1992;41:361-8.
5. Young CY-F, Andrews PE, Montgomery BT, Tindall DJ. Tissue specific and hormonal regulation of human prostate specific glandular kallikrein. Biochemistry 1992;31:818-24.
6. Perry JE, Tindall DJ. Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaP. Cancer Res 1996;56:1539-44.
7. Culig Z, Hobisch A, Cronauer MV, Cato AC, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 1993:7:1541-50.
8. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 1995;332:1393-8.
9. Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, Barrack ER. Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci USA 1992;89:6319-23.
10. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM, Verleun-Mooijman MC, Trapman J, Brinkmann AO, Santerse AB, Schroder FH, van der Kwast TH. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 1994; 144:735-46.
11. Gaddipati JP, McLeod DG, Heidenberg HB, Sesterhenn LA, Finger MJ, Moul JW, Srivastava S. Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 1994;54:2861-4.
12. Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J. Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Molec Biol 1993;46:759-65.
13. Visakorpi T, Kallioniemi AH, Syvänen A-C, Hyytinen E, Karhu R, Tammela T, Isola J, Kallioniemi O-P. Gains and losses of DNA sequences in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995a;55:342-7.
14. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman FM, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
15. Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen L-C, Smith HS, Waldman FM, Pinkel D, Gray JW. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 1992;89:5321-5.
16. Hyytinen E, Visakorpi T, Kallioniemi A, Kallioniemi O-P, Isola J. Improved technique for analysis of formalin-fixed,' paraffin-embedded tumors by fluorescence in situ hybridization. Cytometry 1994; 16:93-9.
17. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi O-P. In vivo amplification of the andrdgen receptor gene and progression of human prostate cancer. Nature Genet 1995;9:401-6.
18. Göker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y, Schnieders B, Steinherz P, Tan C, Berman E, Bertino JR. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoplastic leukemia and is correlated with p53 gene mutations. Blood 1995;86:677-84.
19. Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi O-P. Androgen receptor gene amplification: A possible molecular mechanism for failure of androgen deprivation therapy in prostate cancer. Submitted for publication, 1996.